Sphingolipid metabolism correlates with cerebrospinal fluid Beta amyloid levels in Alzheimer's disease - Wikidata - awgldk - TriplyDB

Sphingolipid metabolism correlates with cerebrospinal fluid Beta amyloid levels in Alzheimer's disease

Sphingolipid metabolism correlates with cerebrospinal fluid Beta amyloid levels in Alzheimer's disease

http://www.wikidata.org/entity/Q35566575

about

The Molecular Mechanism of Amyloid β42 Peptide Toxicity: The Role of Sphingosine Kinase-1 and Mitochondrial Sirtuins ABCA1-Mediated Cholesterol Efflux Capacity to Cerebrospinal Fluid Is Reduced in Patients With Mild Cognitive Impairment and Alzheimer's Disease.Common disease signatures from gene expression analysis in Huntington's disease human blood and brain Role of sphingomyelinases in neurological disorders.Metabolic network failures in Alzheimer's disease: A biochemical road map.Crosstalk between sphingolipids and vitamin D3: potential role in the nervous system.The Association Between Plasma Ceramides and Sphingomyelins and Risk of Alzheimer's Disease Differs by Sex and APOE in the Baltimore Longitudinal Study of Aging.Effects of dietary glucocerebrosides from sea cucumber on the brain sphingolipid profiles of mouse models of Alzheimer's disease.Differential regulation of sphingolipid metabolism in plasma, hippocampus, and cerebral cortex of mice administered sphingolipid modulating agents.Enhanced release of acid sphingomyelinase-enriched exosomes generates a lipidomics signature in CSF of Multiple Sclerosis patients.Particular CSF sphingolipid patterns identify iNPH and AD patients Evaluation of serum sphingolipids and the influence of genetic risk factors in age-related macular degeneration

P2860

Q35763022-0C7199B4-EB4B-41E0-9666-3B5137D09781 Q36713957-4A8EAC34-4BA8-495B-B321-196CD2B83661 Q37141460-C3763C3A-2C2E-43D7-BC47-35D53DC7C203 Q38560939-F10CA30A-2EC6-4387-BE9C-1DE2A3527402 Q38877855-561D93C8-B3B9-4C18-8E98-903CCFE99D95 Q39106107-75CBA00D-68F2-4303-B7D7-9225F5C91EAE Q40401973-F18CF7DD-3C49-42D1-85B6-B3942230B19C Q46413209-2FF6D386-D8DD-40A4-BA23-F9776CD06573 Q46426783-32460339-79F8-4301-A8C9-782D8B6217D3 Q49957703-F6675ED8-659B-4C50-856F-8272F7207F81 Q58751934-20607147-21F5-4046-8E5C-68E144D9582D Q58803874-4BF06477-CC58-4157-94B4-30A15A3E5B82

P2860

Sphingolipid metabolism correlates with cerebrospinal fluid Beta amyloid levels in Alzheimer's disease

http://www.wikidata.org/entity/Q35566575

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Sphingolipid metabolism correl ...... levels in Alzheimer's disease

@ast

Sphingolipid metabolism correl ...... levels in Alzheimer's disease

@en

type

label

Sphingolipid metabolism correl ...... levels in Alzheimer's disease

@ast

Sphingolipid metabolism correl ...... levels in Alzheimer's disease

@en

prefLabel

Sphingolipid metabolism correl ...... levels in Alzheimer's disease

@ast

Sphingolipid metabolism correl ...... levels in Alzheimer's disease

@en

P1433

Q35566575-10ACF8FD-3854-4355-9511-7001305D6897

P1476

Q35566575-9D36EF33-07B5-409D-B86D-09F5F3E21DBE

P2093

Q35566575-33A50DBD-3070-4C7E-B5C1-840D0808AFED

Q35566575-698C9B22-3364-43F3-8FA2-92CE18410CBA

Q35566575-8BF4924E-05A3-4F55-95B4-D4D594433F86

Q35566575-957AB3CB-A161-4147-8E4E-0A10B2A1DE2A

Q35566575-AB8230CB-1646-4A43-87A5-D78BAD7F805E

P2860

Q35566575-019C9EA8-FAB0-4B68-AB13-8B0DF6D0FF8C

Q35566575-054B4254-C2D2-40F4-B0A2-7B1E79770FF8

Q35566575-073653A1-6854-4835-A98A-3ECE3347345F

Q35566575-080C8356-1F0A-4B2E-B4DF-E0972591A352

Q35566575-088AD0AA-8B34-4C63-880F-FA4EFBE2BD69

Q35566575-09B78D1D-C6A2-4876-8218-2811385186B4

Q35566575-108EAAEA-80A0-492F-B784-5E48AF019079

Q35566575-12080224-1C7A-455F-8488-F30628DFEC7D

Q35566575-138C29C2-1534-490D-A487-F4CA317E4362

Q35566575-1A721E4F-41FE-4B35-B603-E8660E4E96E0

P304

Q35566575-A26E8EFD-4C44-48BC-BC0D-90CB3B729258

P31

Q35566575-E90361B3-6292-45EC-9306-038BEDEC644F

P356

Q35566575-BAE8659B-F66B-41A7-A7C2-1A22E5872750

P407

Q35566575-BA8CA72F-202E-4269-9EB0-A33C1981DD59

P433

Q35566575-5A7D1A8C-6FA4-48EF-85CB-A9E05955DA56

P478

Q35566575-4FAF672D-A2E7-43C2-97B0-D686AFF97989

P50

Q35566575-1309EEE0-6863-41D6-8683-C4B122FCE8F6

P577

Q35566575-013A28F5-22FF-446C-A934-C3884251ADAC

P5875

Q35566575-B6EF2A81-EA42-4687-8A83-53D239B6308A

P698

Q35566575-5859A070-273C-4CBC-B724-CA8A8655569B

P921

Q35566575-94D59D12-1A41-453E-8D64-D0D16D20F321

Q35566575-9C2FFD67-C490-4DCE-B931-D8FB9F4DF667

P932

Q35566575-E791DC8B-5662-4B9A-BFB9-A67A0AB93224

P356

JOURNAL.PONE.0125597

P1433

P1476

Sphingolipid metabolism correl ...... levels in Alzheimer's disease

@en

P2093

Alfred N Fonteh

http://www.w3.org/2001/XMLSchema#string

Cora Ormseth

http://www.w3.org/2001/XMLSchema#string

Jiarong Chiang

http://www.w3.org/2001/XMLSchema#string

Matthew Cipolla

http://www.w3.org/2001/XMLSchema#string

Xianghong Arakaki

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of novel functional inhibitors of acid sphingomyelinase

A comprehensive classification system for lipids

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION

Acid and neutral sphingomyelinases: roles and mechanisms of regulation

Potential mechanisms contributing to sulfatide depletion at the earliest clinically recognizable stage of Alzheimer's disease: a tale of shotgun lipidomics

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

Epidemiological and economic burden of Alzheimer's disease: a systematic literature review of data across Europe and the United States of America.

Sphingolipids in inflammation: roles and implications.

Identification of disease markers in human cerebrospinal fluid using lipidomic and proteomic methods

P304

e0125597

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0125597

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Michael Harrington

P577

2015-05-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276502917

http://www.w3.org/2001/XMLSchema#string

P698

25938590

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

cerebrospinal fluid

P932

4418746

http://www.w3.org/2001/XMLSchema#string